Department of Psychiatry & Behavioral Sciences

Clinical Trials

Below is a list of current clinical trials being conducted within the Department of Psychiatry & Behavioral Sciences.  All advertised clinical trials have been approved by the EVMS Institutional Review Board (IRB).

1:

Study Title: A trial of D-cycloserine to treat the social deficit in older adolescents and young adults with Autism Spectrum Disorders

Protocol Summary: A study for a new investigational treatment for the social problems of Autism Spectrum Disorders

Basic Eligibility Criteria:

1. 1. Be healthy young adults between the age of 14 and 25
   2. Have a diagnosis of Autism Spectrum Disorders
   3. Have been on stable medication for at least 4 weeks

Study Site Location: EVMS

Contact for further information: 757-446-5102

2:

Study Title: Donepezil's effect on cardiac function in patients with Alzheimer's Disease through an in vivo, non invasive measure of peripheral neurocholinergic function: Relation to therapeutic efficacy

Protocol Summary: The study will include a baseline session and 2 follow-up sessions that will take place 3 and 6 months after the initial visit. Both sessions will take no more than 90 minutes to complete. The baseline session will include informed consent, a psychosocial evaluation, medical/psychiatric history, mental and thinking tests (cognitive measures), electrocardiogram (EKG) to measure heart rate, blood pressure, and a blood sample (baseline session only). Follow-up sessions will include any changes in medical history since the baseline session, mental and thinking tests, and an EKG

Basic Eligibility Criteria:

1. 1. Aged 60-85
   2. Taking the medication Donepezil (Aricept) for less than 2 years but have started the medication prior to the first session
   3. Diagnosed with Alzheimer's Disease
   4. Free of heart problems such as stroke or arrhythmias

Study Site Location: EVMS - Department of Neuropsychology, Suite 244, Andrews Hall (or the participant's home upon request)

Contact for further information: Lewis Hackett, MA at 734-255-9618 or 757-446-5604.  You may also contact Mr. Hackett via email at: This e-mail address is being protected from spambots. You need JavaScript enabled to view it

3:

Study Title: Transcranial Magnetic Stimulation in treating Psychiatric disorders

Protocol Summary: The goal of the study is to establish a data bank with information routinely employed in clinical practice on patients receiving Transcranial Magnetic Stimulation (TMS) for the treatment of cognitive, emotional, and behavioral disorders (e.g., Major Depressive Disorder, Obsessive-Compulsive Disorder, and Post Traumatic Stress Disorder). This data bank will be used to monitor and evaluate factors that may optimize or possibly hinder the effectiveness of TMS treatment in humans

Basic Eligibility Criteria:

1. 1. Adult (age 18-89) subject receiving TMS treatment at EVMS

Study Site Location: EVMS

Contact for further information: Department of Psychiatry and Behavioral Sciences at 757-446-5888 or This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Return to Psychiatry Main Page